Cargando…
MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity
Therapeutic DNA-based vaccines aim to prime an adaptive host immune response against tumor-associated antigens, eliminating cancer cells primarily through CD8(+) cytotoxic T cell-mediated destruction. To be optimally effective, immunological adjuvants are required for the activation of tumor-specifi...
Autores principales: | Collinson-Pautz, Matthew R., Slawin, Kevin M., Levitt, Jonathan M., Spencer, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065236/ https://www.ncbi.nlm.nih.gov/pubmed/27741278 http://dx.doi.org/10.1371/journal.pone.0164547 |
Ejemplares similares
-
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies
por: Collinson-Pautz, Matthew R., et al.
Publicado: (2019) -
MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
por: Mata, Melinda, et al.
Publicado: (2015) -
MyD88 contribution to ocular surface homeostasis
por: Reins, Rose Y., et al.
Publicado: (2017) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022)